Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction

Jan-Quinten Mol1, Rick H J A Volleberg1, Anouar Belkacemi2

  • 1Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

JAMA Cardiology
|September 13, 2023
PubMed

Insights

High-risk plaques in nonculprit lesions after myocardial infarction (MI) are linked to worse outcomes. Optical coherence tomography (OCT) identified these plaques, suggesting a need for new treatments beyond FFR-guided revascularization.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Patients with myocardial infarction (MI) experience high rates of recurrent major adverse cardiovascular events (MACE) even after fractional flow reserve (FFR)-guided complete revascularization.
  • FFR-negative nonculprit lesions may harbor high-risk plaques contributing to these recurrences.

Purpose of the Study:

  • To evaluate the association between optical coherence tomography (OCT)-identified high-risk plaques in FFR-negative nonculprit lesions and the occurrence of MACE in MI patients.

Main Methods:

  • PECTUS-obs study enrolled patients with MI undergoing OCT on FFR-negative nonculprit lesions (FFR > 0.80).
  • High-risk plaque defined by ≥2 criteria: lipid arc ≥90°, fibrous cap <65 μm, or plaque rupture/thrombus.
  • Compared MACE rates (all-cause mortality, nonfatal MI, unplanned revascularization) at 2-year follow-up.

Main Results:

  • 143 of 420 patients (34.0%) had at least one high-risk plaque.
  • MACE occurred in 15.4% of patients with high-risk plaques vs. 8.3% without (HR, 1.93; P=.02).
  • Unplanned revascularizations were higher in the high-risk plaque group (9.8% vs. 4.3%; P=.02).

Conclusions:

  • High-risk plaques in FFR-negative nonculprit lesions are associated with worse clinical outcomes in MI patients.
  • The increased MACE risk is primarily driven by unplanned revascularizations.
  • Findings suggest a need for novel therapeutic strategies targeting high-risk plaques beyond current revascularization guidelines.
Abstract